Article
Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
Journal of immunology (Baltimore, Md. : 1950) - 1 Mar 2001
Polakos N K, Drane D, Cox J, Ng P, Selby M J, Chien D, O'Hagan D T, Houghton M, Paliard X
Abstract excerpt
Current therapies for the treatment of hepatitis C virus (HCV) infection are only effective in a restricted number of patients. Cellular immune responses, particularly those mediated by CD8(+) CTLs, are thought to play a role in the control of infection and the response to antiviral therapies. Be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
